Philip Morris International

Designing a 
Smoke-Free Future

How long will PMI be in the cigarette business?


Global Launch of IQOS 3 and IQOS 3 Multi

Learn more

Strong Public Support for Alternatives to Cigarettes

View more
Our 40% reduction in GHG emissions by 2030 across our value chain is in clear sight with a 30% reduction already achieved. We’re joining ...
“The multinational environment at PMI has expanded my horizons and brought me out of my comfort zone,” says Vladimir from #Serbia. Want t...
All News
Science & Innovation

Pioneering the way to a smoke-free future

We're at the forefront of developing less harmful alternatives to cigarettes.

Read more

This site is operated for the purpose of providing general information about us. The site is not operated for advertising or marketing purposes. The material on this site should not be regarded as an offer to sell, or a solicitation of an offer to buy, any product of PMI. Such products are sold only in compliance with the laws of the particular jurisdictions in which they are sold. IQOS and other smoke-free products under development by PMI are not currently available in the U.S. PMI has submitted applications seeking authorization to market IQOS in the U.S. from the Food and Drug Administration (FDA). These applications are currently under review by the FDA.